awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33411277-0D6771ED-93FC-43A5-B703-D98C42A9C0C3
Q33411277-0D6771ED-93FC-43A5-B703-D98C42A9C0C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411277-0D6771ED-93FC-43A5-B703-D98C42A9C0C3
Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
P2860
Q33411277-0D6771ED-93FC-43A5-B703-D98C42A9C0C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33411277-0D6771ED-93FC-43A5-B703-D98C42A9C0C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e55534979c022d32e4a25c7fa3e451de94df7ad6
P2860
Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.